1. Home
  2. WHG vs CNTB Comparison

WHG vs CNTB Comparison

Compare WHG & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

N/A

Current Price

$17.11

Market Cap

156.2M

Sector

Finance

ML Signal

N/A

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

N/A

Current Price

$2.20

Market Cap

135.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WHG
CNTB
Founded
1983
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.2M
135.7M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
WHG
CNTB
Price
$17.11
$2.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
9.4K
187.2K
Earning Date
04-30-2026
08-13-2026
Dividend Yield
3.58%
N/A
EPS Growth
203.85
N/A
EPS
0.09
N/A
Revenue
$97,762,000.00
$64,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$191.89
N/A
Revenue Growth
3.21
N/A
52 Week Low
$14.70
$0.77
52 Week High
$18.99
$3.82

Technical Indicators

Market Signals
Indicator
WHG
CNTB
Relative Strength Index (RSI) 60.64 41.11
Support Level $16.82 $2.03
Resistance Level $17.22 $2.68
Average True Range (ATR) 0.56 0.19
MACD 0.12 -0.01
Stochastic Oscillator 72.70 11.48

Price Performance

Historical Comparison
WHG
CNTB

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: